Literature DB >> 27780576

Bile Cast Nephropathy Caused by Obstructive Cholestasis.

Julien Aniort1, Anaïs Poyet2, Jean-Louis Kemeny3, Carole Philipponnet2, Anne-Elisabeth Heng2.   

Abstract

Acute kidney injury (AKI) is a major complication in patients with liver disease. Although hepatorenal syndrome is frequently involved, bile cast nephropathy, characterized by tubular bile cast formation, has been scarcely described in the setting of severe liver failure. Few renal histology studies are available in these patients. We describe a case of bile cast nephropathy in a patient with obstructive cholestasis caused by stones in the common bile duct. The kidney biopsy confirmed this diagnosis, with several green casts in tubular lumens, tubular injury, and bilirubin composition of the tubular casts with Hall stain. The patient had no confounding cause of kidney failure, and complete kidney recovery followed removal of the bile duct obstruction. This case shows that severe cholestasis is sufficient to cause AKI, and that AKI can be reversible after treatment of the biliary obstruction.
Copyright © 2016 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholestasis; acute kidney injury (AKI); bile cast nephropathy; bile duct obstruction; cholemic nephrosis; kidney biopsy; obstructive cholestasis; renal failure

Mesh:

Year:  2016        PMID: 27780576     DOI: 10.1053/j.ajkd.2016.08.023

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  11 in total

Review 1.  Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis.

Authors:  Juan Carlos Q Velez; George Therapondos; Luis A Juncos
Journal:  Nat Rev Nephrol       Date:  2019-11-13       Impact factor: 28.314

2.  Renal tubular injury in hyperbilirubinemia: Bile cast nephropathy.

Authors:  Xun Zhao; Ruiyao Huang; Philip Wong; Pierre-Oliver Fiset; Marc Deschênes
Journal:  Can Liver J       Date:  2021-08-09

3.  The activation of nuclear factor-E2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling blunts cholestasis-induced liver and kidney injury.

Authors:  Khadijeh Mousavi; Hossein Niknahad; Huifeng Li; Zhipeng Jia; Ram Kumar Manthari; Yangfei Zhao; Xiong Shi; Yuanyu Chen; Asrin Ahmadi; Negar Azarpira; Bahman Khalvati; Mohammad Mehdi Ommati; Reza Heidari
Journal:  Toxicol Res (Camb)       Date:  2021-08-04       Impact factor: 2.680

4.  Taurine mitigates the development of pulmonary inflammation, oxidative stress, and histopathological alterations in a rat model of bile duct ligation.

Authors:  Mohammad Mehdi Ommati; Ali Mobasheri; Yanqin Ma; Dongmei Xu; Zhongwei Tang; Ram Kumar Manthari; Narges Abdoli; Negar Azarpira; Yu Lu; Issa Sadeghian; Abolghasem Mousavifaraz; Ali Nadgaran; Ahmad Nikoozadeh; Sahra Mazloomi; Pooria Sayar Mehrabani; Mohammad Rezaei; Hu Xin; Yang Mingyu; Hossein Niknahad; Reza Heidari
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-09-13       Impact factor: 3.195

5.  Apoptosis-inducing factor plays a role in the pathogenesis of hepatic and renal injury during cholestasis.

Authors:  Vahid Ghanbarinejad; Akram Jamshidzadeh; Bahman Khalvati; Omid Farshad; Huifeng Li; Xiong Shi; Yuanyu Chen; Mohammad Mehdi Ommati; Reza Heidari
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-02-01       Impact factor: 3.000

6.  Silymarin mitigates bile duct obstruction-induced cholemic nephropathy.

Authors:  Mohammad Mehdi Ommati; Omid Farshad; Negar Azarpira; Elmira Ghazanfari; Hossein Niknahad; Reza Heidari
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-02-04       Impact factor: 3.000

7.  Bile Cast Nephropathy: A Pathologic Finding with Manifold Causes Displayed in an Adult with Alcoholic Steatohepatitis and in a Child with Wilson's Disease.

Authors:  Jose Torrealba; Nathan T Sweed; Daniel Burguete; Allen R Hendricks
Journal:  Case Rep Nephrol Dial       Date:  2018-09-27

Review 8.  Acute kidney injury in children with chronic liver disease.

Authors:  Akash Deep; Romit Saxena; Bipin Jose
Journal:  Pediatr Nephrol       Date:  2018-03-01       Impact factor: 3.714

9.  Pentoxifylline mitigates cholestasis-related cholemic nephropathy.

Authors:  Mohammad Mehdi Ommati; Sara Hojatnezhad; Narges Abdoli; Ram Kumar Manthari; Zhipeng Jia; Asma Najibi; Amin Reza Akbarizadeh; Issa Sadeghian; Omid Farshad; Negar Azarpira; Hossein Niknahad; Reza Heidari
Journal:  Clin Exp Hepatol       Date:  2021-11-25

10.  LCAT protects against Lipoprotein-X formation in a murine model of drug-induced intrahepatic cholestasis.

Authors:  Marcelo J A Amar; Lita A Freeman; Takafumi Nishida; Maureen L Sampson; Milton Pryor; Boris L Vaisman; Edward B Neufeld; Sotirios K Karathanasis; Alan T Remaley
Journal:  Pharmacol Res Perspect       Date:  2019-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.